CONGRESS COVERAGE: EHA/ICML 2021 – FOCUS ON NHL/CLL

Explore the latest therapeutic developments and translational research in NHL and CLL treatment, advances in dynamic and oftentimes individualized clinical decision-making, and how emerging data will affect ongoing research, development of new compounds, and future treatment paradigms

June 29, 2021
Purchase Report

Faculty Chair

Brad S. Kahl, MD

Washington University School of Medicine, St. Louis, MO, USA

Faculty Members

Raul Cordoba, MD, PhD
Fundacion Jimenez Diaz University Hospital, Madrid, Spain

Pier Luigi Zinzani, MD, PhD
University of Bologna, Bologna, Italy

Paolo Caimi, MD
Case Comprehensive Cancer Center, Cleveland, OH, USA

Stefan K. Barta, MD, MS
University of Pennsylvania Health System, Philadelphia, PA

Andrew Davies, MD
University of Southampton School of Medicine, Southampton, UK

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Update on DLBCL
  • Update on Indolent NHLs (FL and MCL)
  • Update on T-Cell Lymphoma
  • Update on CLL
  • Other NHL

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.